Emergent Biosolutions Inc. Stock
A loss of -2.320% shows a downward development for Emergent Biosolutions Inc..
Our community is currently high on Emergent Biosolutions Inc. with 4 Buy predictions and 0 Sell predictions.
With a target price of 12 € there is a hugely positive potential of 68.4% for Emergent Biosolutions Inc. compared to the current price of 7.13 €.
Our community identified positive and negative aspects for Emergent Biosolutions Inc. stock for the coming years. 1 users see the criterium "Company culture" as a plus for the Emergent Biosolutions Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Emergent Biosolutions Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Emergent Biosolutions Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc. | -2.320% | 3.545% | -2.088% | 72.501% | -31.415% | -24.312% | -89.573% |
| United Therapeutics | -0.140% | 7.679% | 17.137% | 83.227% | 14.533% | 129.120% | 198.415% |
| Novocure Ltd | -1.290% | -3.525% | -20.677% | -39.357% | -19.347% | -83.950% | -91.924% |
| Agios Pharmaceuticals Inc. | -1.960% | 19.531% | 27.500% | 21.429% | 31.897% | 42.991% | -31.467% |
Comments
Emergent Biosolutions (NYSE:EBS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for EBS provided by MarketBeat
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for EBS provided by MarketBeat